MedPath
HSA Approval

ZIMIEX TABLET 10MG

SIN15183P

ZIMIEX TABLET 10MG

ZIMIEX TABLET 10MG

February 28, 2017

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence HolderTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET

ORAL

Medical Information

C10AX09

ezetimibe

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Watson Pharma Private Limited

Balkanpharma-Dupnitsa AD[Primary & Secondary packing]

Actavis Ltd

Active Ingredients

Ezetimibe

10 mg

Ezetimibe

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.